Clinical Trial Update: U69-CART-Cells For R/R T-ALL [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of U69-CART-Cells for relapsed/refractory T-lymphoblastic leukemia/lymphoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma

Drugs mentioned

• U69-CART-Cells

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma | Phase 1 | Status: RECRUITING